FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
Mengmeng Niu(United States Food and Drug Administration), Zhi‐Xiong Jim Xiao(University of Electronic Science and Technology of China)
Cited by 62
Related Papers
The landscape of aging
|Science China Life Sciences|2022|404
USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity
|Nature Communications|2022|53
The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness
|Cancers|2020|46
Nutlin-3 Affects Expression and Function of Retinoblastoma Protein
|Journal of Biological Chemistry|2009|33
Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α
|Cell Death and Differentiation|2024|25